Medicskin Holdings Limited

SEHK:8307 Stock Report

Market Cap: HK$58.3m

Medicskin Holdings Past Earnings Performance

Past criteria checks 0/6

Medicskin Holdings has been growing earnings at an average annual rate of 24.2%, while the Healthcare industry saw earnings growing at 4.8% annually. Revenues have been declining at an average rate of 2.5% per year.

Key information

24.2%

Earnings growth rate

19.4%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate-2.5%
Return on equity-20.4%
Net Margin-3.5%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Sep 15
We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

Sep 16
Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Jul 18
Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Jun 11
Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Feb 25
A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

Sep 15
Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Feb 11
Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

Dec 16
Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

Revenue & Expenses Breakdown
Beta

How Medicskin Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:8307 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2351-200
30 Jun 2349-300
31 Mar 2346-300
31 Dec 2241-200
30 Sep 2243-100
30 Jun 2246200
31 Mar 2249400
31 Dec 21491-10
30 Sep 2147100
30 Jun 2145200
31 Mar 2142100
31 Dec 2042120
30 Sep 2043-120
30 Jun 2045-230
31 Mar 2048-340
31 Dec 1951-360
30 Sep 1952-3150
30 Jun 1952-5140
31 Mar 1951-5130
31 Dec 1852-2170
30 Sep 1853-170
30 Jun 1855170
31 Mar 1858370
31 Dec 1761380
30 Sep 1763380
30 Jun 1763380
31 Mar 1762380
31 Dec 1660350
30 Sep 1659250
30 Jun 1658250
31 Mar 1660250
31 Dec 1562450
30 Sep 1564350
30 Jun 1565350
31 Mar 1567350
31 Dec 1468240
31 Mar 14651440

Quality Earnings: 8307 is currently unprofitable.

Growing Profit Margin: 8307 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 8307 is unprofitable, but has reduced losses over the past 5 years at a rate of 24.2% per year.

Accelerating Growth: Unable to compare 8307's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 8307 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).


Return on Equity

High ROE: 8307 has a negative Return on Equity (-20.39%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.